Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients.

Lei GongRonghui HeYanjun XuTaobo LuoKaixiu JinWuzhou YuanZengguang ZhengLanxuan LiuZebin LiangAo LiZhiguo ZhengHui Li

Published in: Thoracic cancer (2021)

NAL is a useful biomarker for lung SCC prognosis and prediction of chemotherapy responses in Chinese patients. The predictive value of NAL for adjuvant immunotherapy should be further explored in patients with resected NSCLC.

Keyphrases

small cell lung cancer
early stage
lymph node
locally advanced
advanced non small cell lung cancer
prognostic factors
radiation therapy
rectal cancer
tyrosine kinase